THC Biomed Intl Ltd.
THCBF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -35.1% | -9.7% | 180.5% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -42% | -84.1% | 77.6% | 100.9% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -66.8% | -131.3% | 29% | -805.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -125.2% | -168.5% | -3.9% | -852.5% |
| EPS Diluted | -0.019 | -0.039 | -0.001 | -0.096 |
| % Growth | 51.9% | -3,790% | 99% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |